Todd C. Brady
President and CEO · Aldeyra Therapeutics, Inc.
- 2025
- Jun 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd C. Brady files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Douglas - $98K in ALDX purchases and sales in the last 12 months
- Roger M. Klein - $96K in EVOK purchases and sales in the last 12 months
- Michael Alfieri - $7K in ALDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd C. Brady?
Todd C. Brady is a corporate insider, tracked as President and CEO of Aldeyra Therapeutics, Inc. (ALDX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Todd C. Brady last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2025.
Has Todd C. Brady been buying or selling stock?
Recorded transactions: 1 open-market purchase ($418K) and 0 open-market sales across all tracked filings.
